News
Japan health panel recommends allowing import, use of medical marijuana products

TOKYO, Sept 29 (Reuters) – A Japanese health ministry panel on Thursday recommended revising the nation’s drug laws to allow for the importation and use of medicinal marijuana products.
The recommendation was based on meeting medical needs and to harmonise Japan with international standards, the committee said in a report. The revision would apply to marijuana products whose safety and efficacy were confirmed under laws governing pharmaceuticals and medical devices.
Japan has very strict laws banning the importation, production, and use of illicit substances. The committee’s report noted that only 1.4% of people in Japan had ever used marijuana, compared to 20-40% in Western countries.
Revision of the law would be necessary for the use of the cannabis-derived epilepsy drug Epidiolex, which is currently undergoing clinical trials in Japan, the report said.
Reporting by Rocky Swift
Editing by Raissa Kasolowsky
Our Standards: The Thomson Reuters Trust Principles.
Read the full article here
-
Videos1 week ago
'Tokelahoma': Red State Becomes Wild West of Weed Where Chinese Nationals Own 75% of the Farms
-
Videos1 week ago
Traffic stop yields over 200 pounds of marijuana
-
Videos1 week ago
Massachusetts' top cannabis regulator, Shannon O'Brien, suspended
-
Videos3 days ago
Video: Smugglers Offload Sacks Of Drugs To Evade Police In Dramatic Chase
-
Videos5 days ago
Cannabis Stocks & MSOS: Week-End News | SAFE Banking Act!
-
Videos6 days ago
Police Pursued Ganja Mafia Dramatically; Mafia Tossed Marijuana Bags From Moving Vehicle
-
Videos7 days ago
West Harford man speaks after arrested for growing marijuana in his backyard
-
Videos5 days ago
Breaking News: New York's Final Cannabis Regulations Revealed!